Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Am J Public Health. 2010 Oct;100(10):1841-4. doi: 10.2105/AJPH.2010.193060. Epub 2010 Aug 19.

HPV vaccination's second act: promotion, competition, and compulsion.

Author information

  • Center forBioethics and Department of History andSociology of Science, University ofPennsylvania, Philadelphia, PA 19104, USA. jlschwa2@mail.med.upenn.edu

Abstract

Developments regarding human papillomavirus (HPV) vaccines will transform HPV vaccination in the United States while simultaneously raising several new policy and ethical concerns. Policymakers, vaccine manufacturers, and the public health community must now respond to the presence of competing vaccines that are similar but distinct, particularly with respect to genital wart prevention and the benefits of vaccinating males. This work arises in the shadow of the contentious introduction of the HPV vaccine Gardasil (Merck & Co, Inc, Whitehouse Station, NJ) in 2006, particularly the opposition to efforts in many states to require the vaccine for school attendance. I review the current status of HPV vaccine policy in the United States and examine issues of public health ethics and policy central to ongoing and future HPV vaccination programs.

PMID:
20724671
[PubMed - indexed for MEDLINE]
PMCID:
PMC2936995
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon Icon for PubMed Central
    Loading ...
    Write to the Help Desk